Immunomodulation by immunopeptides and autoantibodies in aging, autoimmunity, and infection

Annals of the New York Academy of Sciences

Volumn 1057, Issue , 2005, Pages 247-259

  Marchalonis, J J ^a   Schluter, S F ^a   Sepulveda, R T ^a   Watson, R R ^b   Larson, D F ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cardiopathology; Coxsackievirus; Cytokines; Immunosenescence; Retrovirus; T cell receptors; TCR V ; TH1; TH2

Indexed keywords

AUTOANTIBODY; CYTOKINE; IMMUNOPEPTIDE; PEPTIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR VBETA CHAIN; UNCLASSIFIED DRUG;

AGING; ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE; COLLAGEN SYNTHESIS; CONFERENCE PAPER; COXSACKIE VIRUS; CYTOKINE PRODUCTION; FIBROBLAST; HEART DISEASE; HEART INJURY; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSENESCENCE; INFECTION; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; RETROVIRUS; SENESCENCE; T LYMPHOCYTE;

ANIMALIA; COXSACKIEVIRUS;

EID: 32244439306     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1356.019     Document Type: Conference Paper

References (47)

1. KLEIN, S.A. et al. 1997. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11: 1111-1118.
2. CLERICI, M. & G.M. SHEARER. 1993. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 3: 107-111.
3. HUANG, D.S. et al. 1993. The kinetics of cytokine secretion and proliferation by mesenteric lymph node cells during the progression to murine AIDS, caused by LP-BM5 murine leukemia virus infection. Reg. Immunol. 5: 325-331.
4. + subset regulation in viral infection. Preferential activation of the Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J. Immunol. 148: 182-188.
5. RAFI, A. et al. 2003. Immune dysfunction in the elderly and its reversal by antihistamines. Biomed. Pharmacother. 57: 246-250.
6. DENG, Y. et al. 2004. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J. Immunol. 172: 3437-3446.
7. BOREN, E. et al. 2004. Inflamm-aging: autoimmunity and the immune-risk phenotype. Autoimmun. Rev. 3: 401-406.
8. SKAPENKO, A. et al. 2005. The role of the T cell in autoimmune inflammation. Arthritis Res. Ther. 7: S4-14.
9. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34-38.
10. ROBEY, I.F. et al. 2002. Human monoclonal natural autoantibodies against the T cell receptor inhibit interleukin-2 production in murine T cells. Immunology 105: 419-429.
11. SCHLUTER, S.F. et al. 2003. Natural autoantibodies to TCR public idiotopes: Potential roles in immunomodulation. Cell Mol. Biol. 49: 193-207.
12. WATSON, R.R. et al. 1995. T cell receptor V beta complementarity- determining region 1 peptide administration moderates immune dysfunction and cytokine dysregulation induced by murine retrovirus infection. J. Immunol. 155: 2282-2291.
13. MARCHALONIS, J.J. et al. 2001. T cell receptor-derived peptides in immunoregulation and therapy of retrovirally induced immunosuppression. Crit. Rev. Immunol. 21: 57-74.
14. LIANG B. et al. 1998. Injection of T cell receptor peptide reduces immunosenescence in aged C57B1/6 mice. Immunology 93: 462-468.
15. SEPULVEDA, R.T., J.J. MARCHALONIS & R.R. WATSON. 2005. T cell receptor V beta 8.1 peptide reduces coxsackievirus-induced cardiopathology in aged mice. Cardiovasc. Toxicol. 5: 21-28.
16. MARCHALONIS, J.J. et al. 1992. Human autoantibodies reactive with synthetic autoantigens from T cell receptor beta chain. Proc. Natl. Acad. Sci. USA 89: 3325-3329.
17. MARCHALONIS, J.J. et al. 1993. Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease. Gerontology 39: 65-79.
18. MARCHALONIS, J.J. et al. 2002. Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system. FASEB J. 16: 842-848.
19. DEHGHANPISHEH, K. et al. 1995. Production of IgG autoantibodies to TCRs in mice infected with the retrovirus LP-BM5. 7: 31-36.
20. ADELMAN, M.K., S.F. SCHLUTER & J.J. MARCHALONIS. 2004. The natural antibody repertoire of sharks and humans recognizes the potential universe of antigens. Protein J. 23: 103-118.
21. MARCHALONIS, J.J. et al. 1998. Phylogenetic emergence and molecular evolution of the immunoglobulin family. Adv. Immunol. 70: 417-506.
22. MARCHALONIS, J.J. et al. 1993. Human autoantibodies to a synthetic putative T cell receptor beta-chain regulatory idiotype: expression in autoimmunity and aging. 10: 1-15.
23. WANG, E. et al. 1994. IgG autoantibodies to "switch peptide" determinants of TCR alpha/beta in human pregnancy. Clin. Immunol. Immunopathol. 73: 224-228.
24. MARCHALONIS, J.J. et al. 1996. Autoantibodies to T cell receptor beta chains in human heart transplantation: epitope and spectrotype analyses and kinetics of response. Exp. Clin. Immunogenet. 13: 181-191.
25. LAKE, D.F. et al. 1994. Autoantibodies to the alpha/beta T cell receptors in human immunodeficiency virus infection: dysregulation and mimicry. Proc. Natl. Acad. Sci. USA 91: 10849-10853.
26. MARCHALONIS, J.J. et al. 1997. Analysis of autoantibodies to T cell receptors among HIV-infected individuals: epitope analysis and time course. Clin. Immunol. Immunopathol. 82: 174-189.
27. MARCHALONIS, J.J. et al. 1994. Synthetic autoantigens of immunoglobulins and T cell receptors: their recognition in aging, infection, and auto immunity. Proc. Soc. Exp. Biol. Med. 207: 129-147.
28. JAMBOU, F. et al. 2003. Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis. J. Clin. Invest. 112: 265-274.
29. JAMBOU, F. & S. COHEN-KAMINSKY. 2003. Immunoregulation by Vbeta specific anti-bodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy. Cell Mol. Biol. 49: 181-192.
30. HASHIM, G.A. et al. 1992. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain. J. Immunol. 149: 2803-2809.
31. VAINIENE M. et al. 1996. Natural immunodominant and experimental autoimmune encephalomyelitis-protective determinants within the Lewis rat V beta 8.2 sequence include CDR2 and framework 3 idiotopes. J. Neurosci. Res. 43: 137-145.
32. KURT, R.A. et al. 1995. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities. J. Immunol. 154: 3969-3974.
33. DEHGHANPISHEH, K. & J.J. MARCHALONIS. 1997. Retrovirally induced mouse anti-TCR monoclonals can synergize the in vitro proliferative T cell response to bacterial superantigens. Scand. J. Immunol. 45: 645-654.
34. ROBEY, I.F. et al. 2000. Production and characterization of monoclonal IgM autoanti-bodies specific for the T-cell receptor. J. Protein Chem. 19: 9-21.
35. ROBEY, I.F. et al. 2002. Specificity mapping of human anti-T cell receptor monoclonal natural antibodies: defining the properties of epitope recognition promiscuity. FASEB J. 16: 642-652.
36. LIANG, B. et al. 1996. Effects of vaccination against different T cell receptors on maintenance of immune function during murine retrovirus infection. Cell Immunol. 172: 126-134.
37. LIANG, B. et al. 1996. T cell-receptor dose and the time of treatment during murine retrovirus infection for maintenance of immune function. Immunology 87: 198-204.
38. LIANG, B.L. et al. 1997. Prevention of immune dysfunction, vitamin E deficiency, and loss of Cryptosporidium resistance during murine retrovirus infection by T cell receptor peptide immunization. Nutr. Res. 17: 677-692.
39. SEPULVEDA, R.T., J.J. MARCHALONIS & R.R. WATSON. 2003. T cell receptor V beta 8.1 peptide reduces coxsackievirus-induced cardiopathology during murine acquired immunodeficiency syndrome. J. Cardiovasc. Pharmacol. 41: 489-497.
40. MAKINODAN T. & M.M.B. KAY. 1980. Age influence of the immune system. Adv. Immunol. 29: 287-330.
41. NOBREGA, A. et al. 1996. The age-associated increase in autoreactive immunoglobulins reflects a quantitative increase in specificities detectable at lower concentration in young mice. Scand. J. Immunol. 44: 437-443.
42. KAY, M.M. et al. 1990. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites. Proc. Natl. Acad. Sci. USA 87: 5734-3738.
43. ARKING, R. 1998. Biology of Aging. Sinauer Associates, Inc. Sunderland, MA.
44. ORTMAN, C.L. et al. 2002. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int. Immunol. 14: 813-822.
45. MILLER, R. 1990. Aging and the immune response. In Biology of Aging, 3rd edit. E.L. Schneider and J.W. Rowe, Eds.: 157-180. Academic Press, Inc. San Diego, CA.
46. YU, Q. et al. 2005. A role for T-lymphocytes in mediating cardiac diastolic function. Am. J. Physiol. In press.
47. JERNE, N.K. 1984. Idiotypic networks and other preconceived ideas. Immunol. Rev. 79: 5-24.